Filing Details
- Accession Number:
- 0001179110-17-010382
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-07-14 16:26:50
- Reporting Period:
- 2017-07-13
- Filing Date:
- 2017-07-14
- Accepted Time:
- 2017-07-14 16:26:50
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
792977 | Amag Pharmaceuticals Inc. | AMAG | Pharmaceutical Preparations (2834) | 042742593 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1643127 | Julie Krop | C/O Amag Pharmaceuticals, Inc. 1100 Winter Street Waltham MA 02451 | Svp Clinical & Regulatory, Cmo | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2017-07-13 | 4,938 | $20.00 | 28,336 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- The reported transaction on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 16, 2016.